Zams, Austria

Michael Hauser

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biomay Ag. Active years: 2015.

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Hauser: Innovator in Hypoallergenic Molecules

Introduction

Michael Hauser is a notable inventor based in Zams, Austria. He has made significant contributions to the field of allergy research, particularly through his innovative work on hypoallergenic molecules. His dedication to improving the quality of life for allergy sufferers is evident in his patented inventions.

Latest Patents

Michael Hauser holds a patent for hypoallergenic molecules. The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia. This invention comprises mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v Ia. This patent highlights his commitment to advancing allergy treatment options.

Career Highlights

Michael Hauser is associated with Biomay AG, a company that focuses on biotechnological innovations. His work at Biomay AG has allowed him to collaborate with other experts in the field, further enhancing his contributions to allergy research.

Collaborations

Some of his notable coworkers include Gabriele Gadermaier and Barbara Bohle. Their collaborative efforts have played a crucial role in the development of innovative solutions for allergy-related issues.

Conclusion

Michael Hauser's work in hypoallergenic molecules represents a significant advancement in allergy research. His contributions through patents and collaborations continue to pave the way for improved treatments for allergy sufferers.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…